Palisade Bio, Inc. (PALI)

Palisade Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9.82	12.43	12.38	10.5	0.71
Short-Term Investments	0.01	-	-	-	0.02
Cash & Short-Term Investments	9.83	12.43	12.38	10.5	0.73
Cash Growth	-20.91%	0.40%	17.99%	1339.64%	-79.73%
Other Receivables	0.02	0.15	1.44	0.15	0.06
Receivables	0.02	0.15	1.44	0.15	0.06
Prepaid Expenses	0.56	0.64	0.8	0.86	0.07
Other Current Assets	0.08	0.11	0.11	-	0.04
Total Current Assets	10.49	13.33	14.73	11.51	0.9
Property, Plant & Equipment	0.09	0.21	0.31	0.11	0.28
Long-Term Deferred Charges	-	-	-	-	1.82
Other Long-Term Assets	0.3	0.52	0.72	0.89	0.03
Total Assets	10.88	14.05	15.76	12.51	3.02
Accounts Payable	1.11	0.7	1.76	1.32	2.54
Accrued Expenses	1.96	1.61	1.06	0.97	4.33
Current Portion of Long-Term Debt	0.08	0.16	0.09	0.09	1.05
Current Portion of Leases	0.09	0.12	0.11	0.11	0.17
Total Current Liabilities	3.24	2.59	3.01	2.5	8.08
Long-Term Debt	-	-	-	-	0.09
Long-Term Leases	-	0.09	0.21	-	0.11
Other Long-Term Liabilities	0.15	0.06	0.06	2.65	1.83
Total Liabilities	3.39	2.74	3.28	5.15	10.12
Common Stock	0.03	0.01	0.03	0	0.03
Additional Paid-In Capital	143.41	132.81	121.64	102	51.4
Retained Earnings	-135.94	-121.51	-109.19	-94.64	-68.03
Total Common Equity	7.49	11.31	12.48	7.36	-16.6
Shareholders' Equity	7.49	11.31	12.48	7.37	-7.1
Total Liabilities & Equity	10.88	14.05	15.76	12.51	3.02
Total Debt	0.17	0.37	0.4	0.2	1.42
Net Cash (Debt)	9.66	12.06	11.98	10.3	-0.69
Net Cash Growth	-19.89%	0.70%	16.35%	-	-
Net Cash Per Share	6.82	26.45	204.12	826.06	-
Filing Date Shares Outstanding	4.4	0.85	0.3	0.02	102.04
Total Common Shares Outstanding	2.77	0.62	0.2	0.02	102.04
Working Capital	7.26	10.74	11.72	9.01	-7.19
Book Value Per Share	2.71	18.30	63.57	387.81	-0.16
Tangible Book Value	7.49	11.31	12.48	7.36	-16.6
Tangible Book Value Per Share	2.71	18.30	63.57	387.81	-0.16

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q